Gland Pharma has informed that the Earnings Call for Investors/Analysts will be held on Monday, November 3, 2025, at 18:30 hours (IST) for 60 minutes to discuss the Company's financial performance and business updates for the quarter and half year ended September 30, 2025. The details of the Earnings Call for Investors/Analysts are enclosed. The transcript and the audio recording of the Earnings Call will be made available on the Company’s website.
The above information is a part of company’s filings submitted to BSE.